鑫富药业

- 002019

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
单位:元   
鑫富药业(002019) 利润表
报告期2008-06-302008-03-312007-12-312007-09-302007-06-30
一、主营业务收入295,993,704155,456,620764,741,629547,920,713334,292,243
折扣与折让00000
主营业务收入净额295,993,704155,456,620764,741,629547,920,713334,292,243
主营业务成本142,780,25661,291,899275,527,752202,526,217132,858,232
主营业务税金及附加4,018,1392,150,38811,147,9547,828,5553,200,208
二、主营业务利润149,195,30992,014,333478,065,923337,565,940198,233,804
其他业务利润00000
存货跌价损失00000
营业费用16,574,48910,205,28743,140,63334,691,77823,117,237
管理费用38,048,12819,780,47462,238,54643,176,18526,928,770
财务费用7,277,0225,795,70920,205,55713,954,2719,912,861
三、营业利润89,745,49457,295,203348,718,380243,373,995135,562,007
投资收益871,770516,0541,539,6201,156,1520
补贴收入00000
营业外收入2,905,611610,3331,756,9671,883,8831,208,740
营业外支出1,687,259627,1083,279,3312,049,4431,294,298
以前年度损益调整00000
营业外收支净额1,218,352-16,775-1,522,364-165,560-85,558
四、利润总额91,835,61557,794,482348,735,636244,364,586135,476,448
所得税23,124,54915,677,698108,546,30084,257,36847,446,381
财政返还00000
少数股东权益00000
购买日前净利润00000
未确认的投资损失00000
五、净利润68,711,06642,116,784240,189,336160,107,21888,030,068
年初未分配利润00000
调整以前年度损益00000
盈余公积转入00000
住房周转金转入00000
其他转入00000
六、可分配利润00000
提取法定盈余公积00000
提取法定公益金00000
职工奖金福利00000
提取储备基金00000
提取企业发展基金00000
七、可供股东分配的利润00000
应付优先股股利00000
提取任意盈余公积金00000
应付普通股股利00000
转作股本的普通股股利00000
八、未分配利润00000
鑫富药业(002019) 利润表
报告期2007-03-312006-12-312006-09-302006-06-302006-03-31
一、主营业务收入134,911,923346,404,621257,313,582172,864,52395,388,309
折扣与折让00000
主营业务收入净额134,911,923346,404,621257,313,582172,864,52395,388,309
主营业务成本70,056,294224,954,467173,201,368120,890,75268,521,470
主营业务税金及附加1,252,5443,104,3602,477,9441,761,310767,070
二、主营业务利润63,603,084118,345,79581,634,27050,212,46126,099,768
其他业务利润01,322,219736,601390,640139,953
存货跌价损失00000
营业费用14,273,16653,790,60529,831,42819,265,3909,890,665
管理费用14,727,63539,805,18525,882,19714,264,2775,775,453
财务费用5,211,85012,502,5257,721,0285,036,1492,220,935
三、营业利润28,109,12913,569,69818,936,21812,037,2858,352,669
投资收益0-6,202,037-5,222,483-3,464,448-2,209,663
补贴收入0390,000140,000140,00040,000
营业外收入1,41056,90726,7761,248477
营业外支出685,3761,303,307840,881508,682196,265
以前年度损益调整00000
营业外收支净额-683,966-1,246,399-814,105-507,434-195,788
四、利润总额27,425,1626,511,26213,039,6298,205,4035,987,217
所得税9,378,7014,566,4994,603,7482,592,7311,946,739
财政返还00000
少数股东权益07,93315,56415,56415,564
购买日前净利润00000
未确认的投资损失00000
五、净利润18,046,4621,936,8318,420,3175,597,1074,024,914
年初未分配利润078,708,18778,708,18778,708,18778,708,187
调整以前年度损益00000
盈余公积转入00000
住房周转金转入00000
其他转入00000
六、可分配利润080,645,01787,128,50484,305,29482,733,101
提取法定盈余公积0162,008000
提取法定公益金00000
职工奖金福利00000
提取储备基金00000
提取企业发展基金00000
七、可供股东分配的利润080,483,01087,128,50484,305,29482,733,101
应付优先股股利00000
提取任意盈余公积金00000
应付普通股股利010,237,50010,237,50010,237,5000
转作股本的普通股股利00000
八、未分配利润070,245,51076,891,00474,067,79482,733,101
鑫富药业(002019) 利润表
报告期2005-12-312005-09-302005-06-302005-03-312004-12-31
一、主营业务收入269,314,416207,105,281134,010,85158,012,334245,057,646
折扣与折让00000
主营业务收入净额269,314,416207,105,281134,010,85158,012,334245,057,646
主营业务成本188,725,216142,981,85789,231,42340,083,401164,217,710
主营业务税金及附加2,557,0362,013,1661,151,215295,9361,383,847
二、主营业务利润78,032,16462,110,25843,628,21317,632,99679,456,089
其他业务利润1,313,359663,909427,986186,5131,209,695
存货跌价损失00000
营业费用13,219,00910,076,1366,205,0002,566,8809,576,676
管理费用27,415,75021,681,45712,303,6203,636,31029,620,100
财务费用7,260,3134,368,1732,166,267892,6971,548,179
三、营业利润31,450,45126,648,40123,381,31310,723,62339,920,828
投资收益-5,298,647-1,814,066-49,577-24,7880
补贴收入440,000270,00090,00090,000912,358
营业外收入87,81457,0461,9341,934269,813
营业外支出1,028,507659,095548,655320,7451,584,433
以前年度损益调整00000
营业外收支净额-940,694-602,049-546,721-318,810-1,314,620
四、利润总额25,651,11124,502,28522,875,01510,470,02439,518,566
所得税5,139,8468,109,0507,712,2313,425,4087,002,674
财政返还00000
少数股东权益30,29226,778000
购买日前净利润00000
未确认的投资损失00000
五、净利润20,480,97316,366,45615,162,7837,044,61632,515,892
年初未分配利润70,679,29670,679,29670,679,29670,679,29643,040,787
调整以前年度损益00000
盈余公积转入00000
住房周转金转入00000
其他转入00000
六、可分配利润91,160,26987,045,75285,842,07977,723,91275,556,679
提取法定盈余公积1,952,0820003,251,589
提取法定公益金00001,625,795
职工奖金福利00000
提取储备基金00000
提取企业发展基金00000
七、可供股东分配的利润89,208,18787,045,75285,842,07977,723,91270,679,296
应付优先股股利00000
提取任意盈余公积金00000
应付普通股股利10,500,00010,500,00010,500,00010,500,0000
转作股本的普通股股利00000
八、未分配利润78,708,18776,545,75275,342,07967,223,91270,679,296
鑫富药业(002019) 利润表
报告期2004-09-302004-06-302003-12-312002-12-312001-12-31
一、主营业务收入176,801,491113,521,758176,767,037130,946,99891,335,360
折扣与折让00000
主营业务收入净额176,801,491113,521,758176,767,037130,946,99891,335,360
主营业务成本110,572,58368,319,177121,146,18687,711,71454,820,499
主营业务税金及附加983,002676,168911,540658,672435,525
二、主营业务利润65,245,90544,526,41354,709,31242,576,61136,079,336
其他业务利润714,697480,920654,889292,233389,546
存货跌价损失00000
营业费用6,753,0304,125,1726,071,0023,562,8743,090,819
管理费用23,182,17510,041,55816,301,02812,392,2716,241,503
财务费用2,620,5651,976,7883,492,5281,934,2341,465,236
三、营业利润33,404,83328,863,81429,499,64324,979,46625,671,324
投资收益00000
补贴收入1,047,8881,001,326730,3145,377,7140
营业外收入95,92195,9212,032,90569,1430
营业外支出1,067,996620,304387,240557,734344,929
以前年度损益调整00000
营业外收支净额-972,076-524,3831,645,666-488,591-344,929
四、利润总额33,480,64529,340,75731,875,62229,868,58925,326,395
所得税11,959,86810,708,0595,997,9563,802,037604,976
财政返还00000
少数股东权益00000
购买日前净利润00000
未确认的投资损失00000
五、净利润21,520,77718,632,69825,877,66626,066,55224,721,419
年初未分配利润43,040,78743,040,78732,294,77125,738,2024,724,996
调整以前年度损益00000
盈余公积转入00000
住房周转金转入00000
其他转入00000
六、可分配利润64,561,56461,673,48558,172,43751,804,75429,446,415
提取法定盈余公积002,587,7672,606,6552,472,142
提取法定公益金001,293,8831,303,3281,236,071
职工奖金福利00000
提取储备基金00000
提取企业发展基金00000
七、可供股东分配的利润64,561,56461,673,48554,290,78747,894,77125,738,202
应付优先股股利00000
提取任意盈余公积金00000
应付普通股股利0011,250,00000
转作股本的普通股股利00015,600,0000
八、未分配利润64,561,56461,673,48543,040,78732,294,77125,738,202
点击近期部分数据内容 返回页顶